Filtros de búsqueda

Lista de obras de Pierfranco Conte

18F-Fluoroestradiol Positron Emission Tomography in Breast Cancer Patients: Systematic Review of the Literature & Meta-Analysis.

artículo científico publicado en 2016

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

artículo científico publicado en 2015

5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.

artículo científico publicado en 2001

5-fluorouracil administered as a 48-hour semiintermittent infusion in combination with leucovorin, cisplatin and epirubicin: phase II study in advanced gastric cancer patients.

artículo científico publicado en 2004

A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study).

artículo científico publicado en 2017

A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology

article

A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib.

artículo científico publicado en 2016

A catalyst for change: the European cancer Patient's Bill of Rights

artículo científico publicado en 2014

A computational workflow for the design of irreversible inhibitors of protein kinases.

artículo científico publicado en 2010

A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.

artículo científico publicado en 2015

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

artículo científico publicado en 2014

A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2016

A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer

scientific article published on 01 June 1986

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.

artículo científico publicado en 2013

Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer ⬇️

artículo científico publicado el 1 de noviembre de 1991

Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas

artículo científico publicado en 1996

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.

artículo científico publicado en 2003

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.

artículo científico publicado en 2004

Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance.

artículo científico publicado en 2013

Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy

artículo científico publicado en 2010

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

artículo científico

Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).

artículo científico publicado en 2003

Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II study.

artículo científico publicado en 1993

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer.

artículo científico publicado en 2009

Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients

artículo científico publicado en 1993

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

artículo científico publicado en 2006

Anthracyclines-paclitaxel combinations in the treatment of breast cancer.

artículo científico publicado en 1997

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.

artículo científico publicado en 2007

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

artículo científico publicado en 2007

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

artículo científico publicado en 2019

BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis

artículo científico publicado en 2019

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

artículo científico publicado en 2010

Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives.

artículo científico publicado en 2015

Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome

artículo científico publicado en 2016

Biomarkers predicting clinical benefit: fact or fiction?

scientific article published on 01 January 2011

Body Mass Index and Prognosis of Metastatic Breast Cancer Patients Receiving First-Line Chemotherapy

scientific article published on 14 August 2013

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

scientific article published on 20 March 2019

Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature

artículo científico publicado en 2015

CMET-29. HORMONE RECEPTORS STATUS: A STRONG DETERMINANT OF THE KINETICS OF BRAIN METASTASES OCCURRENCE COMPARED WITH HER2 STATUS IN BREAST CANCER

Cancer Control in Central and Eastern Europe

artículo científico publicado en 2016

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

artículo científico publicado en 1991

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

artículo científico publicado en 2006

Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival

scientific article published on 01 September 1989

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

artículo científico publicado en 2017

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group

artículo científico publicado en 1998

Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look

scientific article published on 01 September 1990

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)

scientific article published on 01 July 1996

Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study

scientific article published on 01 July 1988

Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer

artículo científico publicado en 1985

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy

scientific article published on 05 August 2019

Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience

artículo científico publicado en 2020

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations

artículo científico publicado en 2017

Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

artículo científico publicado en 2017

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

artículo científico publicado en 2008

Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report.

artículo científico publicado en 2009

Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer

artículo científico publicado en 2014

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.

artículo científico publicado en 2004

Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature.

artículo científico publicado en 2005

Corrigendum to “Gene expression profiling in breast cancer: A clinical perspective” [The Breast 22 (2013) 109–120]

article

Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

artículo científico publicado en 2015

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

artículo científico

Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies

artículo científico publicado en 2010

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

scientific article published on 01 June 2019

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

artículo científico publicado en 1996

Diagnosis, Management and Clinical Outcome of Bone Metastases in Breast Cancer Patients: Results from a Prospective, Multicenter Study

artículo científico publicado en 2006

Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.

artículo científico publicado en 2017

Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activity

scientific article published on 01 September 1990

Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer

artículo científico publicado en 1997

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

scientific article published on 14 July 2020

Early B lymphocytes in man

artículo científico publicado en 1980

Effects of primary chemotherapy on biological parameters of locally advanced breast cancer

scientific article published on 01 April 1996

Effects of sulfonylureas on tumor growth: a review of the literature

artículo científico publicado en 2013

Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

artículo científico publicado en 2019

Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice.

artículo científico publicado en 2016

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer ⬇️

artículo científico publicado el 21 de enero de 2012

Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

artículo científico publicado en 2008

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.

artículo científico publicado en 2008

Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer

artículo científico publicado en 1994

Epirubicin/vinorelbine as first line therapy in metastatic breast cancer

artículo científico publicado en 1998

Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized con

artículo científico publicado en 2016

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

artículo científico publicado en 2017

European Perspectives: A Dialogue with the European Oncology Community

artículo científico publicado en 2012

Evaluation of taxol cardiotoxicity in metastatic breast cancer

artículo científico publicado en 1993

Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker

artículo científico publicado en 1989

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience

artículo científico publicado en 2017

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.

artículo científico publicado en 2011

Fat grafting for breast cancer patients: From basic science to clinical studies

artículo científico publicado en 2016

Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report

artículo científico publicado en 2013

Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients

scientific article published on 01 April 1997

First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

artículo científico publicado en 2017

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

artículo científico publicado en 2019

Future role of bevacizumab in breast cancer

GD2 expression in breast cancer.

artículo científico publicado en 2017

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study

scientific article published on 01 February 2000

Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens

artículo científico publicado en 2002

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study* ⬇️

artículo científico publicado el 1 de julio de 2001

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC) ⬇️

artículo científico publicado el 16 de noviembre de 2001

Gene expression profiling in breast cancer: a clinical perspective.

artículo científico

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

artículo científico publicado en 2002

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

artículo científico publicado en 2020

Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?

scientific article published on 06 April 2019

High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).

artículo científico publicado en 2001

Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer

artículo científico publicado en 2017

Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer

artículo científico publicado en 2018

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.

artículo científico publicado en 2016

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

artículo científico publicado en 2019

Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

artículo científico publicado en 2019

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials

artículo científico publicado en 2014

Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients.

artículo científico publicado en 2002

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

artículo científico publicado en 2015

In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.

artículo científico publicado en 1990

Incidence and Clinical Impact of Sterilized Disease and Minimal Residual Disease After Preoperative Radiochemotherapy for Rectal Cancer

scientific article published on 01 October 2005

Increased prevalence of primary hyperparathyroidism in treated breast cancer

artículo científico publicado en 2001

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy

artículo científico publicado en 2021

Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug delivery

scientific article published on 01 October 1999

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

artículo científico publicado en 2016

Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell lines.

artículo científico publicado en 1995

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

artículo científico

Interpreting Cancer Biology: Refining Our Therapeutic Algorithm in Breast Cancer ⬇️

artículo científico publicado el 1 de enero de 2013

Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy

artículo científico publicado en 2016

Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.

artículo científico publicado en 2008

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

scientific article published on 01 February 2000

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

artículo científico publicado en 2010

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab

artículo científico publicado en 2017

LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

artículo científico publicado en 2019

Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

artículo científico publicado en 2006

Laparoscopic approach of gastric gastrointestinal stromal tumors (GISTs): is it still a courageous choice? Report of two cases.

artículo científico publicado en 2007

Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).

artículo científico publicado en 2008

Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors

artículo científico publicado en 2000

Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy

artículo científico publicado en 1995

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

article

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.

artículo científico publicado en 2013

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

artículo científico publicado en 2015

MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential

artículo científico publicado en 2013

MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

artículo científico publicado en 2019

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer

artículo científico publicado en 2011

Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agents

artículo científico publicado en 2014

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time

artículo científico publicado en 2018

Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience.

artículo científico publicado en 2011

Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand

artículo científico publicado en 1997

Megestrol acetate: phase II study of a single daily administration in advanced breast cancer

scientific article published on 01 November 1990

Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis

scientific article published on 01 March 2015

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas

artículo científico publicado en 2015

Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy

artículo científico publicado en 2009

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.

artículo científico publicado en 1995

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman

artículo científico publicado en 2016

Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety

artículo científico publicado en 2004

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

artículo científico publicado en 1996

Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).

artículo científico publicado en 2008

Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.

artículo científico publicado en 2008

Neoplastic Pericardial Effusion: A Monocentric Retrospective Study

artículo científico publicado en 2019

Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

artículo científico publicado en 2019

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡

scientific article published on 01 December 2018

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature

artículo científico publicado en 2015

Novel Nuclear Medicine Imaging Applications in Immuno-Oncology

scientific article published on 21 May 2020

Olaparib for advanced breast cancer

scientific article published on 06 April 2020

Olaparib for the treatment of breast cancer

scientific article published on 30 March 2018

OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

scientific article published on 01 April 2019

Oncological care organisation during COVID-19 outbreak

artículo científico publicado en 2020

Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study

scientific article published on 01 September 2000

Ovarian cancer: optimal chemotherapy in relapsed disease.

artículo científico publicado en 2000

PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype

artículo científico publicado en 2020

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab

artículo científico publicado en 2018

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

artículo científico publicado en 2016

Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study

artículo científico publicado en 1996

Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer

scientific article published on 14 April 2020

Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial

scientific article published on 22 August 2019

Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center

artículo científico publicado en 2018

Pemetrexed: a promising new treatment for breast cancer.

artículo científico publicado en 2002

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

artículo científico publicado en 2019

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.

artículo científico publicado en 2012

Pharmacokinetic optimisation of the treatment of cancer with high dose zidovudine.

artículo científico publicado en 1998

Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.

artículo científico publicado en 1999

Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.

artículo científico publicado en 2002

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

artículo científico publicado en 2002

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

artículo científico publicado en 2007

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer

scientific article published on 01 December 1996

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer

scientific article published on 01 September 1996

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma

artículo científico publicado en 1994

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

artículo científico publicado en 2007

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

artículo científico publicado en 2015

Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.

artículo científico publicado en 2009

Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.

artículo científico publicado en 2014

Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

artículo científico publicado en 2011

Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formation.

artículo científico publicado en 1993

Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation ⬇️

artículo científico publicado el 1 de noviembre de 1992

Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma

scientific article published on 01 January 1992

Predictive value of biologic parameters for primary chemotherapy in operable breast cancer.

artículo científico publicado en 2005

Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis

artículo científico publicado en 2012

Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study

artículo científico publicado en 2015

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).

artículo científico publicado en 2008

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

artículo científico publicado en 2013

Primary adrenal gland carcinosarcoma associated with metastatic rectal cancer: A hitherto unreported collision tumor ⬇️

artículo científico publicado el 1 de septiembre de 2011

Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers

artículo científico publicado en 1998

Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives

artículo científico publicado en 2006

Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

scientific article published on 18 April 2007

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

artículo científico publicado en 2015

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

artículo científico publicado en 2017

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.

artículo científico publicado en 2010

Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy

artículo científico publicado en 2005

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

artículo científico publicado en 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

artículo científico publicado en 2015

Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase

scientific article published on 01 January 1986

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.

artículo científico publicado en 2005

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

artículo científico publicado en 2015

Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria

artículo científico publicado en 2006

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

artículo científico publicado en 1999

Pulmonary strongyloidiasis mimicking cancer symptoms: a case of hyperinfection in a patient with metastatic lung cancer.

artículo científico publicado en 2008

Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer

artículo científico publicado en 2011

Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial

artículo científico publicado en 1998

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

scientific article published on 21 June 2016

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Inst

artículo científico publicado en 2004

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

artículo científico publicado en 2005

Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel

artículo científico publicado en 1996

Rare breast cancer subtypes: histological, molecular, and clinical peculiarities

artículo científico publicado en 2014

Recurrent ovarian carcinoma: Salvage treatment with platinum in patients responding to first-line platinum-based regimens

artículo científico publicado en 1993

Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies ⬇️

artículo científico publicado el 1 de agosto de 2013

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

artículo científico publicado en 2019

Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years.

artículo científico publicado en 2005

Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

artículo científico publicado en 2009

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

artículo científico publicado en 2016

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

artículo científico publicado en 2016

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

artículo científico publicado en 2017

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, [...]

artículo científico publicado en 2016

Safety of intravenous and oral bisphosphonates and compliance with dosing regimens

artículo científico publicado en 2004

Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case report.

artículo científico publicado en 2002

Significance of lymph node sampling in epithelial carcinoma of the ovary.

artículo científico publicado en 1997

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.

artículo científico publicado en 2000

Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer

artículo científico publicado en 2019

Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

scientific article published on 02 November 2013

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

artículo científico publicado en 2016

Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II study

scientific article published on 01 January 1995

Surgical margins in head and neck squamous cell carcinoma: what is ‘close’? ⬇️

artículo científico publicado el 28 de diciembre de 2012

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies

artículo científico publicado en 2005

Survival of patients with relapsing breast cancer: analysis of 302 patients

artículo científico publicado en 1986

Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies.

artículo científico publicado en 1994

Synergistic cytotoxic effects of recombinant human tumor necrosis factor and Etoposide (VP16) or Doxorubicin on A2774 human epithelial ovarian cancer cell line.

artículo científico publicado en 1992

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

artículo científico publicado en 2017

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

artículo científico publicado en 1996

Tamoxifen rechallenge

scientific article published on 01 April 1988

Targeting bone metastatic cancer: Role of the mTOR pathway

artículo científico

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

artículo científico publicado en 2019

The European Cancer Patient's Bill of Rights, update and implementation 2016. ⬇️

artículo científico publicado en 2016

The Future of Chemotherapy in the Era of Personalized Medicine

The Next Generation of Biologic Agents: Therapeutic Role in Relation to Existing Therapies in Metastatic Breast Cancer ⬇️

artículo científico publicado el 1 de junio de 2012

The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients.

artículo científico publicado en 2009

The curability of breast cancer and the treatment of advanced disease.

artículo científico publicado en 2004

The impact of received dose intensity on the outcome of advanced ovarian cancer

artículo científico publicado en 1993

The role of surgery in the combined treatment of locally advanced breast cancer

artículo científico publicado en 1989

The sequential use of endocrine treatment for advanced breast cancer: where are we?

artículo científico publicado en 2012

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.

artículo científico publicado en 2015

Therapeutic approaches for T790M mutation positive non-small-cell lung cancer

scientific article published on 14 August 2018

Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy

artículo científico publicado en 1996

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?

artículo científico publicado en 2018

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer

artículo científico publicado en 1990

Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancer

artículo científico publicado en 1984

Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer

scientific article published on 01 January 1990

Timing for starting second-line therapy in recurrent ovarian cancer

scientific article published on January 2011

Trabectedin plus pegylated liposomal doxorubicin: retrospective analysis in heavily pretreated platinum-sensitive ovarian cancer ⬇️

artículo científico publicado en 2015

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

artículo científico publicado en 2016

Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE

scientific article published on 18 July 2019

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

artículo científico publicado en 1995

Treatment of metastatic renal cell carcinoma with constant-rate floxuridine infusion plus recombinant alpha 2b-interferon

artículo científico publicado en 1996

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

artículo científico publicado en 2017

Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer

scientific article published on 01 January 1994

Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy

scientific article published on 19 December 2019

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

artículo científico publicado en 2012

Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer

artículo científico publicado en 2003

Uterine sarcomas: a clinicopathologic study.

artículo científico publicado en 1988

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

scientific article published on 21 November 2019

Weekly Low-Dose Paclitaxel as Maintenance Treatment in Patients With Advanced Ovarian Cancer Who Had Microscopic Residual Disease at Second-Look Surgery After 6 Cycles of Paclitaxel/Platinum-Based Chemotherapy

artículo científico publicado en 2009

Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.

artículo científico publicado en 2002

Whole exome sequencing of rare aggressive breast cancer histologies.

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda